Quantitative detection of free 24S-hydroxycholesterol, and 27-hydroxycholesterol from human serum

BMC Neuroscience

Volumn 15, Issue 1, 2014, Pages

  Bandaru, Veera Venkata Ratnam ^a   Haughey, Norman J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

24S hydroxycholesterol; 27 hydroxycholesterol; Alzheimer's; HIV associated neurocogntiive disorder; LC ESI MS MS; Multiple sclerosis; Serum

Indexed keywords

24S HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; CHOLESTEROL DERIVATIVE; UNCLASSIFIED DRUG; 24-HYDROXYCHOLESTEROL; 27-HYDROXYCHOLESTEROL;

ARTICLE; CHEMICAL STRUCTURE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; DISSOCIATION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MEASUREMENT ACCURACY; MOLECULAR WEIGHT; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; STANDARD; ADULT; BLOOD; BLOOD ANALYSIS; CHEMISTRY; FEMALE; MALE; MASS SPECTROMETRY; PROCEDURES; STANDARDS;

ADULT; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; MALE; MASS SPECTROMETRY;

EID: 84924062839     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/s12868-014-0137-z     Document Type: Article

References (52)

1. Brown AJ, Jessup W: Oxysterols and atherosclerosis. Atherosclerosis 1999, 142(1):1-28.
2. Bjorkhem I, Andersson O, Diczfalusy U, Sevastik B, Xiu RJ, Duan C, Lund E: Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci U S A 1994, 91(18):8592-8596.
3. Brown MS, Goldstein JL: Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. J Biol Chem 1974, 249(22):7306-7314.
4. Kandutsch AA, Chen HW, Shown EP: Binding of 25-hydroxycholesterol and cholesterol to different cytoplasmic proteins. Proc Natl Acad Sci U S A 1977, 74(6):2500-2503.
5. Danielsson H: Present Status of Research on Catabolism and Excretion of Cholesterol. Adv Lipid Res 1963, 1:335-385.
6. Bjorkhem I, Meaney S, Diczfalusy U: Oxysterols in human circulation: which role do they have? Curr Opin Lipidol 2002, 13(3):247-253.
7. Repa JJ, Mangelsdorf DJ: The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000, 16:459-481.
8. Schroepfer GJ Jr: Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 2000, 80(1):361-554.
9. Ares MP, Porn-Ares MI, Thyberg J, Juntti-Berggren L, Berggren PO, Diczfalusy U, Kallin B, Bjorkhem I, Orrenius S, Nilsson J: Ca2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells. J Lipid Res 1997, 38(10):2049-2061.
10. Gabbi C, Kim HJ, Hultenby K, Bouton D, Toresson G, Warner M, Gustafsson JA: Pancreatic exocrine insufficiency in LXRbeta-/- mice is associated with a reduction in aquaporin-1 expression. Proc Natl Acad Sci U S A 2008, 105(39):15052-15057.
11. Kolsch H, Ludwig M, Lutjohann D, Rao ML: Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta. J Neural Transm 2001, 108(4):475-488.
12. Kotti T, Head DD, McKenna CE, Russell DW: Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation. Proc Natl Acad Sci U S A 2008, 105(32):11394-11399.
13. Lahoua Z, Astruc ME, Barjon JN, Michel F, de Crastes Paulet A: Mechanism of the activation of arachidonic acid release by oxysterols in NRK 49 F cells: role of calcium. Cell Signal 1989, 1(6):569-576.
14. Lee CS, Park WJ, Han ES, Bang H: Differential modulation of 7-ketocholesterol toxicity against PC12 cells by calmodulin antagonists and Ca2+ channel blockers. Neurochem Res 2007, 32(1):87-98.
15. Sacchetti P, Sousa KM, Hall AC, Liste I, Steffensen KR, Theofilopoulos S, Parish CL, Hazenberg C, Richter LA, Hovatta O, Gustafsson JA, Arenas E: Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells. Cell Stem Cell 2009, 5(4):409-419.
16. Trousson A, Bernard S, Petit PX, Liere P, Pianos A, El Hadri K, Lobaccaro JM, Ghandour MS, Raymondjean M, Schumacher M, Massaad C: 25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR. J Neurochem 2009, 109(4):945-958.
17. Burkard I, von Eckardstein A, Waeber G, Vollenweider P, Rentsch KM: Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. Atherosclerosis 2007, 194(1):71-78.
18. Dzeletovic S, Breuer O, Lund E, Diczfalusy U: Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem 1995, 225(1):73-80.
19. Ramirez DM, Andersson S, Russell DW: Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J Comp Neurol 2008, 507(5):1676-1693.
20. Heverin M, Meaney S, Lutjohann D, Diczfalusy U, Wahren J, Bjorkhem I: Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J Lipid Res 2005, 46(5):1047-1052.
21. Koschack J, Lutjohann D, Schmidt-Samoa C, Irle E: Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals. Neurobiol Aging 2009, 30(6):898-902.
22. Leoni V, Mariotti C, Tabrizi SJ, Valenza M, Wild EJ, Henley SM, Hobbs NZ, Mandelli ML, Grisoli M, Bjorkhem I, Cattaneo E, Di Donato S: Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. Brain 2008, 131(Pt 11):2851-2859.
23. Lutjohann D, Bjorkhem I, Locatelli S, Dame C, Schmolling J, von Bergmann K, Fahnenstich H: Cholesterol dynamics in the foetal and neonatal brain as reflected by circulatory levels of 24S-hydroxycholesterol. Acta Paediatr 2001, 90(6):652-657.
24. Lutjohann D, Papassotiropoulos A, Bjorkhem I, Locatelli S, Bagli M, Oehring RD, Schlegel U, Jessen F, Rao ML, von Bergmann K, Heun R: Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 2000, 41(2):195-198.
25. Meng LJ, Griffiths WJ, Nazer H, Yang Y, Sjovall J: High levels of (24S)-24-hydroxycholesterol 3-sulfate, 24-glucuronide in the serum and urine of children with severe cholestatic liver disease. J Lipid Res 1997, 38(5):926-934.
26. Papassotiropoulos A, Lutjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, Ptok U, Bjorkhem I, von Bergmann K, Heun R: 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res 2002, 36(1):27-32.
27. Teunissen CE, Floris S, Sonke M, Dijkstra CD, De Vries HE, Lutjohann D: 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. J Neurosci Res 2007, 85(7):1499-1505.
28. Andersson S, Davis DL, Dahlback H, Jornvall H, Russell DW: Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem 1989, 264(14):8222-8229.
29. Cali JJ, Russell DW: Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J Biol Chem 1991, 266(12):7774-7778.
30. Javitt NB: 25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles. J Lipid Res 2002, 43(5):665-670.
31. Esterman AL, Baum H, Javitt NB, Darlington GJ: 26-hydroxycholesterol: regulation of hydroxymethylglutaryl-CoA reductase activity in Chinese hamster ovary cell culture. J Lipid Res 1983, 24(10):1304-1309.
32. Javitt NB: Bile acid synthesis from cholesterol: regulatory and auxiliary pathways. Faseb J 1994, 8(15):1308-1311.
33. Reiss AB, Martin KO, Javitt NB, Martin DW, Grossi EA, Galloway AC: Sterol 27-hydroxylase: high levels of activity in vascular endothelium. J Lipid Res 1994, 35(6):1026-1030.
34. Russell DW: Oxysterol biosynthetic enzymes. Biochim Biophys Acta 2000, 1529(1-3):126-135.
35. Breuer O, Bjorkhem I: Simultaneous quantification of several cholesterol autoxidation and monohydroxylation products by isotope-dilution mass spectrometry. Steroids 1990, 55(4):185-192.
36. Sevanian A, Seraglia R, Traldi P, Rossato P, Ursini F, Hodis H: Analysis of plasma cholesterol oxidation products using gas- and high-performance liquid chromatography/mass spectrometry. Free Radic Biol Med 1994, 17(5):397-409.
37. Csallany AS, Kindom SE, Addis PB, Lee JH: HPLC method for quantitation of cholesterol and four of its major oxidation products in muscle and liver tissues. Lipids 1989, 24(7):645-651.
38. Zhang Z, Li D, Blanchard DE, Lear SR, Erickson SK, Spencer TA: Key regulatory oxysterols in liver: analysis as delta4-3-ketone derivatives by HPLC and response to physiological perturbations. J Lipid Res 2001, 42(4):649-658.
39. Griffiths WJ, Wang Y, Alvelius G, Liu S, Bodin K, Sjovall J: Analysis of oxysterols by electrospray tandem mass spectrometry. J Am Soc Mass Spectrom 2006, 17(3):341-362.
40. Meaney S, Hassan M, Sakinis A, Lutjohann D, von Bergmann K, Wennmalm A, Diczfalusy U, Bjorkhem I: Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study. J Lipid Res 2001, 42(1):70-78.
41. Meaney S, Lutjohann D, Diczfalusy U, Bjorkhem I: Formation of oxysterols from different pools of cholesterol as studied by stable isotope technique: cerebral origin of most circulating 24S-hydroxycholesterol in rats, but not in mice. Biochim Biophys Acta 2000, 1486(2-3):293-298.
42. Babiker A, and Diczfalusy: Transport of side-chain oxidized oxysterols in the human circulation. Biochem Biophysics Acta 1998(1392):333-339.
43. Burkard I, Rentsch KM, von Eckardstein A: Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry. J Lipid Res 2004, 45(4):776-781.
44. van den Kommer TN, Dik MG, Comijs HC, Fassbender K, Lutjohann D, Jonker C: Total cholesterol and oxysterols: early markers for cognitive decline in elderly? Neurobiol Aging 2009, 30(4):534-545.
45. Teunissen CE, De Vente J, von Bergmann K, Bosma H, van Boxtel MP, De Bruijn C, Jolles J, Steinbusch HW, Lutjohann D: Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. Neurobiol Aging 2003, 24(1):147-155.
46. Locatelli S, Lutjohann D, Schmidt HH, Otto C, Beisiegel U, von Bergmann K: Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Arch Neurol 2002, 59(2):213-216.
47. Davis W Jr: The cholesterol transport inhibitor U18666a regulates amyloid precursor protein metabolism and trafficking in N2aAPP "Swedish" cells. Current Alzheimer Res 2008, 5(5):448-456.
48. Davis HR Jr, Murgolo NJ, Graziano MP: Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008, 359(5):531. author reply 532-533.
49. Whitfield JF: The road to LOAD: late-onset Alzheimer's disease and a possible way to block it. Expert Opin Ther Targets 2007, 11(10):1257-1260.
50. Vaya J, Schipper HM: Oxysterols, cholesterol homeostasis, and Alzheimer disease. J Neurochem 2007, 102(6):1727-1737.
51. Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, Lutjohann D, Nitsch RM, Hock C: A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry 2005, 66(7):940-947.
52. Chang TY, Chang CC, Bryleva E, Rogers MA, Murphy SR: Neuronal cholesterol esterification by ACAT1 in Alzheimer's disease. IUBMB Life.